Epilepsy in Children After Pandemic Influenza Vaccination

Pediatrics. 2018 Mar;141(3):e20170752. doi: 10.1542/peds.2017-0752. Epub 2018 Feb 15.

Abstract

Objectives: To determine if pandemic influenza vaccination was associated with an increased risk of epilepsy in children.

Methods: Information from Norwegian registries from 2006 through 2014 on all children <18 years living in Norway on October 1, 2009 was used in Cox regression models to estimate hazard ratios for incident epilepsy after vaccination. A self-controlled case series analysis was used to estimate incidence rate ratios in defined risk periods after pandemic vaccination.

Results: In Norway, the main period of the influenza A subtype H1N1 pandemic was from October 2009 to December 2009. On October 1, 2009, 1 154 113 children <18 years of age were registered as residents in Norway. Of these, 572 875 (50.7%) were vaccinated against pandemic influenza. From October 2009 through 2014 there were 3628 new cases of epilepsy (incidence rate 6.09 per 10 000 person-years). The risk of epilepsy was not increased after vaccination: hazard ratio: 1.07; 95% confidence interval: 0.94-1.23. Results from the self-controlled case series analysis supported the finding of no association between vaccination and subsequent epilepsy.

Conclusions: Pandemic influenza vaccination was not associated with increased risk of epilepsy. Concerns about pandemic vaccination causing epilepsy in children seem to be unwarranted.

MeSH terms

  • Adolescent
  • Child
  • Child, Preschool
  • Epilepsy / epidemiology*
  • Female
  • Humans
  • Incidence
  • Infant
  • Infant, Newborn
  • Influenza A Virus, H1N1 Subtype
  • Influenza Vaccines / adverse effects*
  • Influenza, Human / epidemiology
  • Influenza, Human / prevention & control*
  • Influenza, Human / virology
  • Male
  • Norway / epidemiology
  • Pandemics / prevention & control*
  • Proportional Hazards Models
  • Registries
  • Risk Assessment
  • Seizures, Febrile / etiology
  • Vaccination / adverse effects*

Substances

  • Influenza Vaccines
  • pandemrix